FBXL12 (Gene)

Synonyms:ENTREZ:54850, F-box and leucine rich repeat protein 12, FBXL12, Fbl12, HGNC:13611, MIM:609079, NM_001316936, NM_001316937, NM_001316938, NM_001316939, NM_001316940, NM_001316941, NM_001316942, NM_017703, NP_001303865, NP_001303866, NP_001303867, NP_001303868, NP_001303869, NP_001303870, NP_001303871, NP_060173, XM_006722782, XM_017026912, XP_006722845, XP_016882401
Omim:OMIM:609079
Id:ENSG00000127452
Hgnc:HGNC:13611
Entrez:54850
Description:F-box and leucine rich repeat protein 12
Members of the F-box protein family, such as FBXL12, are characterized by an approximately 40-amino acid F-box motif. SCF complexes, formed by SKP1 (MIM 601434), cullin (see CUL1; MIM 603134), and F-box proteins, act as protein-ubiquitin ligases. F-box proteins interact with SKP1 through the F box, and they interact with ubiquitination targets through other protein interaction domains (Jin et al., 2004 [PubMed 15520277]).[supplied by OMIM, Mar 2008]

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View FBXL12's neighborhood in the knowledge graph.

Playbook Workflow Builder
Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with FBXL12.

Gene Partnership Appyter
CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using FBXL12.

Gene and Drug Landing Page Aggregator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for FBXL12.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with FBXL12.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.